Intellectual property

Nobilis Therapeutics has extensive intellectual coverage on the medical use of noble gases, including its own IP portfolio of 9 patents and an exclusive licensing agreement with Harvard University’s Partners office. Company is also engaged in discussions with third parties on further in-licensing opportunities and plans to file a number of additional in-house generated patents.

Application Number Name of Invention

 

Date of Filing Applicant
62380903 “PREVETION OF PREGNANCY COMPLICATIONS BY NOBLE GAS ADMINISTRATION” 2016-08-29 Nobilis Therapeutics
PCT/US16/39038 “THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS” 2016-06-23 Nobilis Therapeutics
62352497 “TREATMENT OF RHEUMATOID ARTHRITIS USING NOBLE GAS MIXTURES” 2016-06-20 Nobilis Therapeutics
62346608 “MODULATION OF AMYLOID BETA TOXICITY AND PROCESSING BY XENON GAS” 2016-06-07 Nobilis Therapeutics
62343620 “NOBLE GAS NEUROPROTECTION AND NEUROREGENERATION FROM TREATMENT-RELATED NEUROTOXICITY” 2016-05-31 Nobilis Therapeutics
25806964 “AUGMENTATION OF ANTIINFLAMMATORY, IMMUNOMODULATORY, AND REGENERATIVE PROCESSES IN  AMYOTROPHIC LATERAL SCLEROSIS USING XENON AND NOBLE GAS COMBINATIONS” 2016-05-17 Nobilis Therapeutics
62314983 “NOBLE GAS AUGMENTATION OF REGENERATIVE CELL ACTIVITY” 2016-03-29 Nobilis Therapeutics
62276753 “NOBLE GAS TREATMENT OF ALZHEIMER’S DISEASE AND TAUPATHIES” 2016-01-08 Nobilis Therapeutics
62183624 “THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS” 2015-06-23 Nobilis Therapeutics
62/252703
61/735,700
PCT/US13/74007
“XENON AND/OR ARGON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS” Originally filed on 2012-12-11 Licensed by Nobilis Therapeutics from Harvard’s Partners office